Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011 (2011), Article ID 564062, 10 pages
http://dx.doi.org/10.1155/2011/564062
Research Article

The Role of CXCR3 in the Induction of Primary Biliary Cirrhosis

1Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
2Department of Respiratory Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
3Department of Rheumatology, Affiliated Hospital of Qingdao University Medical College, 266053, China

Received 17 October 2010; Revised 9 February 2011; Accepted 24 February 2011

Academic Editor: S. Sozzani

Copyright © 2011 Wen Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. S. He, A. A. Ansari, W. M. Ridgway, R. L. Coppel, and M. E. Gershwin, “New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis,” Cellular Immunology, vol. 239, no. 1, pp. 1–13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Solís Herruzo, P. Solís Muñoz, and T. Muñoz Yagüe, “The pathogenesis of primary biliary cirrhosis,” Revista Espanola de Enfermedades Digestivas, vol. 101, no. 6, pp. 413–423, 2009. View at Google Scholar · View at Scopus
  3. S. Shimoda, K. Harada, H. Niiro et al., “CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis,” Hepatology, vol. 51, no. 2, pp. 567–575, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Colvin, G. S. V. Campanella, J. Sun, and A. D. Luster, “Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function,” Journal of Biological Chemistry, vol. 279, no. 29, pp. 30219–30227, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Lacotte, S. Brun, S. Muller, and H. Dumortier, “CXCR3, inflammation, and autoimmune diseases,” Annals of the New York Academy of Sciences, vol. 1173, pp. 310–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Y. Lee, Z. H. Lee, and Y. W. Song, “CXCL10 and autoimmune diseases,” Autoimmunity Reviews, vol. 8, no. 5, pp. 379–383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. H. Xie, N. Nomura, M. Lu et al., “Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation,” Journal of Leukocyte Biology, vol. 73, no. 6, pp. 771–780, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Ruth, J. B. Rottman, K. J. Katschke et al., “Selective lymphocyte chemokine receptor expression in the rheumatoid joint,” Arthritis and Rheumatism, vol. 44, no. 12, pp. 2750–2760, 2001. View at Google Scholar · View at Scopus
  9. C. Gerard and B. J. Rollins, “Chemokines and disease,” Nature Immunology, vol. 2, no. 2, pp. 108–115, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. K. E. Balashov, J. B. Rottman, H. L. Weiner, and W. W. Hancock, “CCR5 and CXCR3 T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 12, pp. 6873–6878, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Norii, M. Yamamura, M. Iwahashi, A. Ueno, J. Yamana, and H. Makino, “Selective recruitment of CXCR3+ and CCR5+ CD4+ T cells into synovial tissue in patients with rheumatoid arthritis,” Acta Medica Okayama, vol. 60, no. 3, pp. 149–157, 2006. View at Google Scholar · View at Scopus
  12. K. Mohan and T. B. Issekutz, “Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis,” Journal of Immunology, vol. 179, no. 12, pp. 8463–8469, 2007. View at Google Scholar · View at Scopus
  13. P. Enghard, J. Y. Humrich, B. Rudolph et al., “CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients,” Arthritis and Rheumatism, vol. 60, no. 1, pp. 199–206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Wenzel, J. Proelss, A. Wiechert, S. Zahn, T. Bieber, and T. Tüting, “CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus,” Journal of the American Academy of Dermatology, vol. 56, no. 4, pp. 648–650, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. U. P. Singh, C. Venkataraman, R. Singh, and J. W. Lillard, “CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication,” Endocrine, Metabolic and Immune Disorders, vol. 7, no. 2, pp. 111–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Martini, F. Zulian, F. Calabrese et al., “CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis,” Arthritis Research & Therapy, vol. 7, no. 2, pp. R241–R249, 2005. View at Google Scholar · View at Scopus
  17. J. Wenzel, R. Schmidt, J. Proelss, S. Zahn, T. Bieber, and T. Tüting, “Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis,” Clinical and Experimental Dermatology, vol. 31, no. 4, pp. 576–582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. W. Bauer, M. Petri, F. M. Batliwalla et al., “Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study,” Arthritis and Rheumatism, vol. 60, no. 10, pp. 3098–3107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. J. Helbig, A. Ruszkiewicz, L. Semendric, H. A. J. Harley, S. R. McColl, and M. R. Beard, “Expression of the CXCR3 Ligand I-TAC by Hepatocytes in Chronic Hepatitis C and Its Correlation with Hepatic Inflammation,” Hepatology, vol. 39, no. 5, pp. 1220–1229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Zeremski, L. M. Petrovic, L. Chiriboga et al., “Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C,” Hepatology, vol. 48, no. 5, pp. 1440–1450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Perney, C. Turriere, P. Portalès et al., “CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C,” Clinical Immunology, vol. 132, no. 1, pp. 55–62, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Wald, I. D. Weiss, E. Galun, and A. Peled, “Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics,” Cytokine, vol. 39, no. 1, pp. 50–62, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Larrubia, M. Calvino, S. Benito et al., “The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection,” Journal of Hepatology, vol. 47, no. 5, pp. 632–641, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. K. J. Helbig, A. Ruszkiewicz, R. E. Lanford et al., “Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro,” Journal of Virology, vol. 83, no. 2, pp. 836–846, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Bièche, T. Asselah, I. Laurendeau et al., “Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection,” Virology, vol. 332, no. 1, pp. 130–144, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. E. Harvey, J. J. Post, P. Palladinetti et al., “Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation,” Journal of Leukocyte Biology, vol. 74, no. 3, pp. 360–369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Zeremski, L. M. Petrovic, and A. H. Talal, “The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection,” Journal of Viral Hepatitis, vol. 14, no. 10, pp. 675–687, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. R. Larrubia, S. Benito-Martínez, M. Calvino, E. Sanz-de-Villalobos, and T. Parra-Cid, “Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection,” World Journal of Gastroenterology, vol. 14, no. 47, pp. 7149–7159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. P. J. Holst, C. Orskov, K. Qvortrup, J. P. Christensen, and A. R. Thomsen, “CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis,” Journal of Virology, vol. 81, no. 18, pp. 10101–10112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. K. L. Hokeness, E. S. Deweerd, M. W. Munks, C. A. Lewis, R. P. Gladue, and T. P. Salazar-Mather, “CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection,” Journal of Virology, vol. 81, no. 3, pp. 1241–1250, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. H. Chuang, Z. X. Lian, C. M. Cheng et al., “Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives,” Journal of Autoimmunity, vol. 25, no. 2, pp. 126–132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Harada and Y. Nakanuma, “Molecular mechanisms of cholangiopathy in primary biliary cirrhosis,” Medical Molecular Morphology, vol. 39, no. 2, pp. 55–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. W. Cruise, J. R. Lukens, A. P. Nguyen, M. G. Lassen, S. N. Waggoner, and Y. S. Hahn, “Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage,” Journal of Immunology, vol. 176, no. 10, pp. 6235–6244, 2006. View at Google Scholar · View at Scopus
  34. C. Okada, F. Akbar, N. Horiike, and M. Onji, “Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration,” Liver International, vol. 25, no. 3, pp. 595–603, 2005. View at Publisher · View at Google Scholar · View at Scopus